Target intelligence / Profile preview

S100A11 pseudogene 7 (S100A11P7)

Target
S100A11P7
Molecular classification
Other (Pseudogene)
01

Overview

S100A11 pseudogene 7 (S100A11P7) is an annotated pseudogene, meaning it is a DNA sequence related to the functional S100A11 gene but is not expected to produce a functional protein product. Pseudogenes are generally considered non-coding "genomic fossils" resulting from gene duplication or retrotransposition events and are not considered therapeutic or diagnostic targets. There is no evidence that S100A11P7 is expressed as a functional protein, interacts with drugs, or contributes to disease, and it should not be confused with the protein-coding gene S100A11, which is a member of the S100 calcium-binding protein family implicated in processes such as cell growth, apoptosis, and cancer. The S100A11 gene (not the pseudogene) encodes S100 calcium-binding protein A11, which is involved in cell cycle regulation, motility, cytoskeletal dynamics, and is implicated in diseases such as cancer. Pseudogenes such as S100A11P7 do not code for functional proteins unless otherwise demonstrated; thus, they are not considered drug targets, biomarkers, or receptors. No evidence could be found in clinical, molecular, or pharmacological databases to support that S100A11P7 is expressed, functional, or relevant to therapy. S100A11P7 is a pseudogene, not a functional target. Its inclusion as a drug, receptor, or biomarker target is incorrect. If your intent is to study the protein-coding gene involved in biological and disease processes, refer to S100 calcium-binding protein A11 (S100A11) instead.

Other names
S100A11P7S100 calcium-binding protein A11 pseudogene 7S100A11P7 (HGNC symbol, if referenced in certain databases)S100A11 related pseudogene 7

Beyond the preview

Go deeper on S100A11 pseudogene 7 (S100A11P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S100A11 pseudogene 7 (S100A11P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call